Top compounds associated with response to NEURL2


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.068 0.04
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.04
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.04
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.073 0.04
mRNA TW 37 GDSC1000 pan-cancer AAC -0.068 0.04
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.072 0.04
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC 0.11 0.04
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.097 0.04
mRNA Sorafenib CCLE pan-cancer AAC 0.093 0.04
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.071 0.04
Download CSV